Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making

Journal of Multidisciplinary Healthcare
Vaibhav B KatkadeKelly H Zou

Abstract

Evidence from medication use in the real world setting can help to extrapolate and/or augment data obtained in randomized controlled trials and establishes a broad picture of a medication's place in everyday clinical practice. By supplementing and complementing safety and efficacy data obtained in a narrowly defined (and often optimized) patient population in the clinical trial setting, real world evidence (RWE) may provide stakeholders with valuable information about the safety and effectiveness of a medication in large, heterogeneous populations. RWE is emerging as a credible information source; however, there is scope for enhancements to real world data (RWD) sources by understanding their complexities and applying the most appropriate analytical tools in order to extract relevant information. In addition to providing information for clinicians, RWE has the potential to meet the burden of evidence for regulatory considerations and may be used in approval of new indications for medications. Further understanding of RWD collection and analysis is needed if RWE is to achieve its full potential.

Citations

Jan 9, 2019·Journal of Comparative Effectiveness Research·Tine GeldofIsabelle Huys
Aug 16, 2019·Journal of the American Medical Informatics Association : JAMIA·Tina Hernandez-BoussardDan Riskin
Mar 13, 2020·The Journal of Hand Surgery, European Volume·Jennifer C E LaneMatthew D Gardiner
Jul 11, 2020·International Journal of Technology Assessment in Health Care·Ash BullementGemma E Shields
Jul 14, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Eric P Borrelli, Conor G McGladrigan
Jul 14, 2020·Journal of Medical Economics·Kevin BowrinAurélie Millier
Aug 29, 2020·Therapeutic Innovation & Regulatory Science·Alfredo Aram PuliniGregory Katz
Sep 18, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Josep Darbà, Alicia Marsà
Nov 20, 2019·Drugs -- Real World Outcomes·Andrew D XiaMatthew J Hirst
Nov 28, 2019·SLAS Technology·Agata BlasiakTheodore Kee
Apr 1, 2020·Journal of Managed Care & Specialty Pharmacy·Jordan M Mitchell, Julie A Patterson
Jul 7, 2020·Arquivos de neuro-psiquiatria·Bruno Kusznir Vitturi, Rubens José Gagliardi
Jun 12, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Susan RobinsonTessa Kennedy-Martin
Aug 18, 2020·Journal of Multidisciplinary Healthcare·Kelly H ZouAmrit Ray
Nov 10, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Josep Darbà, Alicia Marsà
Dec 6, 2020·Journal of Applied Research in Intellectual Disabilities : JARID·Peter MulhallVivien Coates
Feb 6, 2021·Breast Cancer Research and Treatment·Leonardo Roberto da SilvaLuiz Carlos Zeferino
Feb 25, 2021·International Journal of Technology Assessment in Health Care·Hannah SieversMickaël Hiligsmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.